Detalhe da pesquisa
1.
A new prognostic model for survival in second line for metastatic renal cell carcinoma: development and external validation.
Angiogenesis
; 22(3): 383-395, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739258
2.
No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer.
BMC Cancer
; 19(1): 847, 2019 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462288
3.
Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.
Support Care Cancer
; 25(11): 3365-3373, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28593463
4.
Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
Ann Surg Oncol
; 23(12): 3891-3898, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27352205
5.
New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study.
Stat Med
; 35(19): 3245-58, 2016 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27027783
6.
Group sequential adaptive designs in series of time-to-event randomised trials in rare diseases: A simulation study.
Stat Methods Med Res
; 29(6): 1483-1498, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354106
7.
CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.
Comput Methods Programs Biomed
; 176: 211-223, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200907
8.
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
J Clin Oncol
; 37(14): 1169-1178, 2019 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30807234
9.
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
Int J Radiat Oncol Biol Phys
; 102(5): 1420-1429, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30071296
10.
ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.
Clin Cancer Res
; 24(11): 2517-2529, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581135
11.
Statistical approaches for evaluating body composition markers in clinical cancer research.
Expert Rev Anticancer Ther
; 17(4): 311-318, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28277100
12.
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.
PLoS One
; 12(6): e0178351, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28617804
13.
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients.
Oncotarget
; 7(18): 25549-57, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27016411
14.
Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.
Clin Cancer Res
; 25(4): 1431, 2019 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770490